Apimeds Pharmaceuticals US, Inc. (APUS)
NYSE: APUS · Pharmaceutical Preparations · Matawan, NJ · filing with the SEC since 2024
Filings
92 filings since 2017 beside 38 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026Due next and emerging growth company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files.
Filings a yearinsider forms included
158035
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 12 times in the last 36 months, the newest Oct 1, 2026.Listing warning from its exchange (8-K item 3.01): 1 time in the last 36 months, the newest Apr 22, 2026.SEC letters: 15 in the last 36 months, the newest May 5, 2025.A late-filing notice, Form NT 10-Q, filed May 15, 2026.A late-filing notice, Form NT 10-K, filed Mar 31, 2026.A late-filing notice, Form NT 10-Q, filed Aug 14, 2025.A late-filing notice, Form NT 10-Q, filed May 15, 2025.A late-filing notice, Form NT 10-K, filed Mar 31, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Sep 23, 2026
8-K items 3.03, 5.03, 9.01
Change to shareholders' rights; Charter, bylaw or fiscal-year change · Current report
Jul 24, 2026
Sep 11, 2026
8-K items 1.01, 5.02, 9.01
Major agreement signed; Officer or director change · Current report
Sep 10, 2026
May 4, 2026
8-K items 1.01, 5.02, 8.01, 9.01
Major agreement signed; Officer or director change; Other event · Current report
Apr 24, 2026
Apr 9, 2026
8-K/A items 5.02, 5.03, 8.01, 9.01
Officer or director change; Charter, bylaw or fiscal-year change; Other event · Current report, amended
Mar 20, 2026
Mar 26, 2026
8-K items 5.02, 5.03, 8.01, 9.01
Officer or director change; Charter, bylaw or fiscal-year change; Other event · Current report
Mar 20, 2026
Mar 25, 2026
8-K items 5.02, 5.03, 8.01, 9.01
Officer or director change; Charter, bylaw or fiscal-year change; Other event · Current report
Mar 20, 2026
Feb 17, 2026
8-K/A items 2.01, 9.01
Purchase or sale of a business completed · Current report, amended
Dec 1, 2025
Dec 10, 2025
8-K/A items 1.01, 3.03, 5.03, 9.01
Major agreement signed; Change to shareholders' rights; Charter, bylaw or fiscal-year change · Current report, amended
Dec 1, 2025
Dec 2, 2025
8-K items 1.01, 2.01, 2.03, 3.02, 5.01, 5.02, 5.03, 7.01, 9.01
Major agreement signed; Purchase or sale of a business completed; New debt or obligation taken on; Shares sold without registration; Change of control; Officer or director change; Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report
Dec 1, 2025
Oct 16, 2025
8-K items 5.03, 9.01
Charter, bylaw or fiscal-year change · Current report
Oct 15, 2025
40 of 92 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.